Azienda bavarese di biomateriali avanzati a base di proteine della seta prodotte da microrganismi.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Funding round AMSilk raised €52 million (€30 in equity, €22 in convertible bonds) led by ATHOS to scale industrial production of its silk-based biomaterials. | $60.3M |